Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
NCT ID: NCT00319306
Last Updated: 2009-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
550 participants
INTERVENTIONAL
2005-09-30
2006-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults
NCT00385593
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
NCT01360021
Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting
NCT00235911
SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults
NCT00238784
Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice
NCT00782314
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Budesonide/formoterol
Symbicort® Turbohaler®
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Confirmed diagnosis of mild to moderate asthma by doctor
* Currently receiving inhaled corticoid-steroid medicine for treatment of asthma and requiring a review of current asthma treatment
Exclusion Criteria
* Patients with a history of chronic obstructive pulmonary disease
* Patients using any beta blocker therapy
* Patients receiving steroid tablets or steroid injections
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Iain Small, MD
Role: PRINCIPAL_INVESTIGATOR
General Practitioner
AstraZeneca UK Medical Director, MD
Role: STUDY_DIRECTOR
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Fowey, Cornwall, United Kingdom
Research Site
Hove, East Sussex, United Kingdom
Research Site
Ilford, Essex, United Kingdom
Research Site
Glenrothes, Fife, United Kingdom
Research Site
Dartford, Kent, United Kingdom
Research Site
Airdrie, Lanarkshire, United Kingdom
Research Site
Hamilton, Lanarkshire, United Kingdom
Research Site
Doncaster, North Yorkshire, United Kingdom
Research Site
Cookstown, Northern Ireland, United Kingdom
Research Site
Downpatrick, Northern Ireland, United Kingdom
Research Site
Barry, South Glamorgan, United Kingdom
Research Site
Chase Terrace, Staffordshire, United Kingdom
Research Site
East Horsley, Surrey, United Kingdom
Research Site
Crawley, West Sussex, United Kingdom
Research Site
Box, Wiltshire, United Kingdom
Research Site
Bradford-on-Avon, Wiltshire, United Kingdom
Research Site
Ashford, , United Kingdom
Research Site
Atherstone, , United Kingdom
Research Site
Ayrshire, , United Kingdom
Research Site
Bath, , United Kingdom
Research Site
Blackpool, , United Kingdom
Research Site
Bolton, , United Kingdom
Research Site
Cardiff, , United Kingdom
Research Site
Carrickfergus, , United Kingdom
Research Site
Cheshire, , United Kingdom
Research Site
Chesterfield, , United Kingdom
Research Site
Coventry, , United Kingdom
Research Site
Dundee, , United Kingdom
Research Site
Ellesmere Port, , United Kingdom
Research Site
Fife, , United Kingdom
Research Site
Glasgow, , United Kingdom
Research Site
Harrow, , United Kingdom
Research Site
Larne, , United Kingdom
Research Site
Leeds, , United Kingdom
Research Site
Middlesbrough, , United Kingdom
Research Site
Newcastle, , United Kingdom
Research Site
Newtownabbey, , United Kingdom
Research Site
Peterhead, , United Kingdom
Research Site
Pontypridd, , United Kingdom
Research Site
Reading, , United Kingdom
Research Site
Rugby, , United Kingdom
Research Site
Rutherglen, , United Kingdom
Research Site
Sandy, , United Kingdom
Research Site
Sheffield, , United Kingdom
Research Site
Stafford, , United Kingdom
Research Site
Stevenage, , United Kingdom
Research Site
Stockport, , United Kingdom
Research Site
Sunbury-on-Thames, , United Kingdom
Research Site
Sutton Coldfield, , United Kingdom
Research Site
Tilehurst, , United Kingdom
Research Site
Tonbridge, , United Kingdom
Research Site
Trowbridge, , United Kingdom
Research Site
Vale of Glamorgan, , United Kingdom
Research Site
Warminster, , United Kingdom
Research Site
Watford, , United Kingdom
Research Site
Wells-next-the-Sea, , United Kingdom
Research Site
Westbury, , United Kingdom
Research Site
Woking, , United Kingdom
Research Site
Yaxley, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RELEASE
Identifier Type: -
Identifier Source: secondary_id
D5890L00012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.